Suppr超能文献

相似文献

1
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
EMBO J. 2004 Jun 16;23(12):2451-8. doi: 10.1038/sj.emboj.7600246. Epub 2004 May 20.
2
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
Virology. 2005 Sep 1;339(2):281-8. doi: 10.1016/j.virol.2005.06.005.
4
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Nat Med. 2003 Nov;9(11):1398-403. doi: 10.1038/nm946. Epub 2003 Oct 5.
5
Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
J Med Invest. 2010 Feb;57(1-2):89-94. doi: 10.2152/jmi.57.89.
7
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
J Virol. 2006 Nov;80(21):10522-33. doi: 10.1128/JVI.01123-06. Epub 2006 Aug 18.
9
Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.
PLoS Pathog. 2009 Feb;5(2):e1000292. doi: 10.1371/journal.ppat.1000292. Epub 2009 Feb 6.
10

引用本文的文献

2
Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction.
J Virol. 2025 Jan 31;99(1):e0160624. doi: 10.1128/jvi.01606-24. Epub 2024 Dec 23.
4
Role of Type I Interferons during and HIV Infections.
Biomolecules. 2024 Jul 14;14(7):848. doi: 10.3390/biom14070848.
5
Structural insights into PPP2R5A degradation by HIV-1 Vif.
Nat Struct Mol Biol. 2024 Oct;31(10):1492-1501. doi: 10.1038/s41594-024-01314-6. Epub 2024 May 24.
6
Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway.
Biophys J. 2024 Feb 6;123(3):294-306. doi: 10.1016/j.bpj.2023.12.015. Epub 2023 Dec 19.
7
Mammalian Genomic Manipulation with Orthogonal Bxb1 DNA Recombinase Sites for the Functional Characterization of Protein Variants.
ACS Synth Biol. 2023 Nov 17;12(11):3352-3365. doi: 10.1021/acssynbio.3c00355. Epub 2023 Nov 3.
9
Molecular Biology and Diversification of Human Retroviruses.
Front Virol. 2022;2. doi: 10.3389/fviro.2022.872599. Epub 2022 Jun 2.
10
Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.
J Mol Biol. 2022 Jan 30;434(2):167355. doi: 10.1016/j.jmb.2021.167355. Epub 2021 Nov 10.

本文引用的文献

2
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3770-4. doi: 10.1073/pnas.0307713101. Epub 2004 Mar 3.
3
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32. doi: 10.1073/pnas.0307132101. Epub 2004 Feb 20.
4
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
J Biol Chem. 2004 Feb 27;279(9):7792-8. doi: 10.1074/jbc.M313093200. Epub 2003 Dec 13.
5
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Curr Biol. 2003 Nov 11;13(22):2009-13. doi: 10.1016/j.cub.2003.10.034.
6
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Science. 2003 Nov 7;302(5647):1056-60. doi: 10.1126/science.1089591. Epub 2003 Oct 16.
8
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Nat Med. 2003 Nov;9(11):1398-403. doi: 10.1038/nm946. Epub 2003 Oct 5.
9
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Nat Med. 2003 Nov;9(11):1404-7. doi: 10.1038/nm945. Epub 2003 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验